COX BRYAN F. (Chief Scientific & Manufact.) sold 1.9% of their position (3.18K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market sale worth $13.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/20/2026ACC: 0001628280-26-020189
Officer· Chief Scientific & Manufact.
Since Aug 2023
-3.18K
Net shares
Net seller
$13.1K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.18K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.14K
Price / share
$4.13
Trade value
$4.70K
% of position
0.7%
3/11/2026
166.60K→165.46K
Common Stock
Direct
Shares
−1.47K
Price / share
$4.09
Trade value
$6K
% of position
0.9%
3/12/2026
165.46K→163.99K
Common Stock
Direct
Shares
−579.00
Price / share
$4.12
Trade value
$2.39K
% of position
0.4%
3/16/2026
163.99K→163.41K
Total
Net shares
−3.18K
Net value
-$13.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −1.14K | $4.13 | $4.70K | 0.7% | 166.60K | 165.46K |
| Common Stock Direct | 3/12/2026 | S · Sale | −1.47K | $4.09 | $6K | 0.9% | 165.46K | 163.99K |
| Common Stock Direct | 3/16/2026 | S · Sale | −579.00 | $4.12 | $2.39K | 0.4% | 163.99K | 163.41K |
| Total | −3.18K | -$13.09K | ||||||
Derivative Transactions0
No derivative transactions reported